Evidence map›Paper›PMID 18837980›Full record

ArticleBMC evolutionary biology2008

The role of positive selection in determining the molecular cause of species differences in disease.

Jessica J Vamathevan, Samiul Hasan, Richard D Emes, Heather Amrine-Madsen, Dilip Rajagopalan, Simon D Topp, Vinod Kumar, Michael Word, Mark D Simmons, Steven M Foord and 3 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in BMC evolutionary biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Genetic Variation and Population Structure ofPathogens (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Genetic diversity and population structure ofJournal of advanced veterinary and animal research · 2024
    Article
  8. Global scenario of genetic diversity inParasite epidemiology and control · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. The influence of 17q21.31 andFrontiers in aging neuroscience · 2022
    Review
  13. Article
  14. Article
  15. Frontiers in aging neuroscience · 2020
    Review
  16. Antagonistic Pleiotropy in Human Disease.Journal of molecular evolution · 2020
    Review
  17. Article
  18. Article
  19. Adaptive molecular evolution ofEcology and evolution · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Jessica J Vamathevan1Department of Biology, University College London, Darwin Bldg, Gower Street, London WC1E 6BT, UK. j.vamathevan@ucl.ac.uk
Samiul Hasan
Richard D Emes
Heather Amrine-Madsen
Dilip Rajagopalan
Simon D Topp
Vinod Kumar
Michael Word
Mark D Simmons
Steven M Foord
Philippe Sanseau
Ziheng Yang
Joanna D Holbrook
GlaxoSmithKline (United States) · USGlaxoSmithKline (United Kingdom) · GBSouth College · USUniversity College London · GBKeele University · GB

Funding

Biotechnology and Biological Sciences Research CouncilMedical Research Council G90/112
6 · The paper itself

Abstract

backgroundRelated species, such as humans and chimpanzees, often experience the same disease with varying degrees of pathology, as seen in the cases of Alzheimer's disease, or differing symptomatology as in AIDS. Furthermore, certain diseases such as schizophrenia, epithelial cancers and autoimmune disorders are far more frequent in humans than in other species for reasons not associated with lifestyle. Genes that have undergone positive selection during species evolution are indicative of functional adaptations that drive species differences. Thus we investigate whether biomedical disease differences between species can be attributed to positively selected genes.

resultsWe identified genes that putatively underwent positive selection during the evolution of humans and four mammals which are often used to model human diseases (mouse, rat, chimpanzee and dog). We show that genes predicted to have been subject to positive selection pressure during human evolution are implicated in diseases such as epithelial cancers, schizophrenia, autoimmune diseases and Alzheimer's disease, all of which differ in prevalence and symptomatology between humans and their mammalian relatives. In agreement with previous studies, the chimpanzee lineage was found to have more genes under positive selection than any of the other lineages. In addition, we found new evidence to support the hypothesis that genes that have undergone positive selection tend to interact with each other. This is the first such evidence to be detected widely among mammalian genes and may be important in identifying molecular pathways causative of species differences.

conclusionOur dataset of genes predicted to have been subject to positive selection in five species serves as an informative resource that can be consulted prior to selecting appropriate animal models during drug target validation. We conclude that studying the evolution of functional and biomedical disease differences between species is an important way to gain insight into their molecular causes and may provide a method to predict when animal models do not mirror human biology.

Indexed as

DiseaseEvolution, MolecularSelection, GeneticAlgorithmsAnimalsBase SequenceCluster AnalysisComputational BiologyDogsGenetic VariationHumansMicePan troglodytesRatsSequence AlignmentSpecies Specificity

Identifiers

PMID18837980
PMCPMC2576240
OpenAlexW2143856819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.